Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Many New Oncology Drugs In 2012, With Prices That Test The Limits

Feb 26 2013

Related Content

Questioning <em>Stivarga</em>’s Cost-Effectiveness In Colon Cancer

Dec 03 2012

GlaxoSmithKline Deals One-Two Punch With BRAF/MEK Pair

Jun 05 2012

Role Of Cost And Evidence In Value-Based Purchasing Highlighted By Zaltrap Price Adjustment

Dec 24 2012

The <em>Zaltrap</em> Price Debate: Less Than Meets The Eye

Nov 20 2012

Dendreon Set To Ship Provenge Within A Week

Apr 29 2010

Related Companies

Dendreon Corporation

Bayer AG

Onyx Pharmaceuticals, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Genentech, Inc.

IQVIA Holdings Inc.

Memorial Sloan Kettering Cancer Center

Johnson & Johnson

Astellas Pharma, Inc.

Medivation, Inc.

Bristol Myers Squibb Company

GSK plc

Additional Topics

United States Pricing Strategies Leadership BioPharmaceutical

More from Leadership

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window